非格司亭（重组甲磺酸去铁胺人粒细胞集落刺激因子）：头10年 - Suppr

Suppr

超能文献

Filgrastim (r-metHuG-CSF): the first 10 years.

作者信息

Welte K, Gabrilove J, Bronchud M H, Platzer E, Morstyn G

机构信息

Medizinische Hochschule, Hannover, Germany.

出版信息

Blood. 1996 Sep 15;88(6):1907-29.

PMID:8822908

Abstract

摘要

相似文献

Filgrastim (r-metHuG-CSF): the first 10 years.非格司亭（重组甲磺酸去铁胺人粒细胞集落刺激因子）：头10年

Blood. 1996 Sep 15;88(6):1907-29.

Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.糖基化和非糖基化重组人粒细胞集落刺激因子在中性粒细胞减少和非中性粒细胞减少的CD大鼠中的效力比较。

Cancer Chemother Pharmacol. 1997;39(3):259-66. doi: 10.1007/s002800050570.

Clinical use of recombinant human G-CSF. Aplastic anemia (AA) and myelodysplastic syndromes (MDS).

J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:349-52. doi: 10.3177/jnsv.38.special_349.

Cost comparison of outpatient treatment with granulocyte colony-stimulating factors (G-CSF) in Germany.德国门诊使用粒细胞集落刺激因子（G-CSF）治疗的成本比较。

Int J Clin Pharmacol Ther. 2012 Apr;50(4):281-9. doi: 10.5414/cp201633.

Biopharmaceutical drug development: Filgrastim (r-metHuG-CSF) use in patients with HIV infection.

J Hematother Stem Cell Res. 1999;8 Suppl 1:S3-8. doi: 10.1089/152581699319858.

The use of Filgrastim in AIDS-related neutropenia.

J Hematother Stem Cell Res. 1999;8 Suppl 1:S9-16. doi: 10.1089/152581699319867.

G-CSF: filgrastim, lenograstim and biosimilars.G-CSF：非格司亭、培非格司亭和生物类似药。

Expert Opin Biol Ther. 2014 Jul;14(7):983-93. doi: 10.1517/14712598.2014.905537. Epub 2014 Apr 7.

Clinical use of recombinant hematopoietic colony-stimulating factors.

Adv Intern Med. 1991;36:329-62.

A systematic review of available clinical evidence - filgrastim compared with lenograstim.对现有临床证据的系统评价——非格司亭与来格司亭的比较。

Int J Clin Pharmacol Ther. 2011 Aug;49(8):510-8. doi: 10.5414/cp201537.

Immune reconstitution: is there a potential role for Filgrastim (r-metHuG-CSF).

J Hematother Stem Cell Res. 1999;8 Suppl 1:S1-2. doi: 10.1089/152581699319849.

引用本文的文献

Evaluation of Neutrophil Elastase Inhibitors as Potential Therapies for Associated Neutropenia.中性粒细胞弹性蛋白酶抑制剂作为相关中性粒细胞减少症潜在治疗方法的评估。

J Cell Immunol. 2024;6(5):211-218. doi: 10.33696/immunology.6.208.

Deciphering the Complexities of Adult Human Steady State and Stress-Induced Hematopoiesis: Progress and Challenges.解读成人人类稳态和应激诱导造血的复杂性：进展与挑战

Int J Mol Sci. 2025 Jan 14;26(2):671. doi: 10.3390/ijms26020671.

Filgrastim Efficiency in Cats Naturally Infected with Feline Panleukopenia Virus.非格司亭对自然感染猫泛白细胞减少症病毒的猫的疗效

Animals (Basel). 2024 Dec 11;14(24):3582. doi: 10.3390/ani14243582.

Flavopiridol restores granulopoiesis in experimental models of severe congenital neutropenia.黄酮哌啶醇可在严重先天性中性粒细胞减少症的实验模型中恢复粒细胞生成。

Mol Ther. 2025 Jun 4;33(6):2851-2871. doi: 10.1016/j.ymthe.2024.10.031. Epub 2024 Dec 8.

Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and endoxan: a prospective randomized controlled clinical trial.探讨多柔比星和环磷酰胺化疗诱导的早期乳腺癌中性粒细胞减少症中聚乙二醇化重组人粒细胞集落刺激因子最佳给药时机的前瞻性随机对照临床试验。

BMC Cancer. 2024 Nov 12;24(1):1387. doi: 10.1186/s12885-024-13156-y.

Implications of glycosylation for the development of selected cytokines and their derivatives for medical use.糖基化对选定细胞因子及其衍生物在医学用途方面的发展的影响。

Biotechnol Adv. 2024 Dec;77:108467. doi: 10.1016/j.biotechadv.2024.108467. Epub 2024 Oct 22.

The Potential Diagnostic Utility of SMAD4 and ACCS in the Context of Inflammation in Type 2 Diabetes Mellitus Patients.SMAD4和ACCS在2型糖尿病患者炎症背景下的潜在诊断效用

Biomedicines. 2024 Sep 4;12(9):2015. doi: 10.3390/biomedicines12092015.

A randomized, multicenter phase III Study of once-per-cycle administration of efbemalenograstim alfa (F-627), a novel long-acting rhG-CSF, for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer.一项随机、多中心 III 期研究，评估了新型长效 rhG-CSF（efbemalenograstim alfa，F-627）在乳腺癌患者中的应用，每周期给药一次，用于预防化疗引起的中性粒细胞减少症。

BMC Cancer. 2024 Sep 13;24(1):1143. doi: 10.1186/s12885-024-12892-5.

Combating bone marrow failure with polymer materials.用聚合物材料治疗骨髓衰竭。

Front Immunol. 2024 Apr 17;15:1396486. doi: 10.3389/fimmu.2024.1396486. eCollection 2024.

A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organism.一种通过半合成生物体设计的用于自身免疫治疗的偏向CD25的白细胞介素-2。

Commun Med (Lond). 2024 Mar 26;4(1):58. doi: 10.1038/s43856-024-00485-z.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验